Innoviva, Inc. (INVA) — Analyst outlook / Analyst consensus target is. Based on 10 analyst ratings, the consensus is bullish — 5 Buy, 4 Hold, 1 Sell.
The consensus price target is $37.67 (low: $32.00, high: $46.00), representing an upside of 55.7% from the current price $24.19.
Analysts estimate Earnings Per Share (EPS) of $0.43 and revenue of $0.35B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.37 vs est $0.43 (missed -12.9%). 2025: actual $4.02 vs est $1.90 (beat +111.5%). Analyst accuracy: 66%.
INVA Stock — 12-Month Price Forecast
$37.67
▲ +55.73% Upside
Average Price Target
Based on 10 Wall Street analysts offering 12-month price targets for Innoviva, Inc., the average price target is $37.67, with a high forecast of $46.00, and a low forecast of $32.00.
The average price target represents a +55.73% change from the last price of $24.19.
Highest Price Target
$46.00
Average Price Target
$37.67
Lowest Price Target
$32.00
INVA Analyst Ratings
Buy
Based on 10 analysts giving stock ratings to Innoviva, Inc. in the past 3 months
EPS Estimates — INVA
66%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $0.37
vs Est $0.43
▼ 14.9% off
2025
Actual $4.02
vs Est $1.90
▲ 52.7% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is improving.
Revenue Estimates — INVA
96%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.359B
vs Est $0.354B
▲ 1.4% off
2025
Actual $0.425B
vs Est $0.399B
▲ 6.1% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
